Addamel

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Addamel

Property Description
Active Ingredients Nine essential trace elements
Form Concentrate for solution for infusion
Pharmacological Class Trace element supplement; Parenteral nutrition additive
General Purpose Correcting or preventing mineral deficiencies
Origin Chemically-defined (inorganic mineral salts)

What Type of Medicine is Addamel? (Classification and Form)

Addamel is classified as a multi-component preparation and belongs to the trace element supplement class, delivered as a concentrate for solution for infusion. It is a prescription-only medicine (POM) intended for intravenous (parenteral) use, ensuring the active substances bypass the digestive system entirely. This approach is clinically recognized for ensuring complete micronutrient bioavailability in patients with compromised gastrointestinal function.

This essential classification places Addamel within the broader group of parenteral nutrition additives, serving a physiological rather than a pharmacological function. The specific form, a sterile, aqueous solution, facilitates its preparation and subsequent safe administration through the patient's vein, adhering to the stringent requirements for parenteral therapy.

Composition: What Essential Trace Elements Does Addamel Contain?

The active composition of Addamel consists of a precisely defined mixture of nine essential trace elements, which the human body cannot produce and must obtain externally. The preparation provides Chromium, Copper, Iron, Manganese, Molybdenum, Iodine, Fluorine, Selenium, and Zinc.

This formulation is chemically-defined and synthetic, developed to deliver a stable, balanced, and comprehensive spectrum of these essential micronutrients. The product’s characteristic feature is its single-vial combination of all nine elements, simplifying the demanding process of preparing total intravenous nutrition solutions.

General Purpose: Why is this Trace Element Supplement Used?

The general purpose of Addamel is to prevent or correct established shortages of these essential trace elements in individuals whose nutritional requirements cannot be met through oral or enteral intake. It is specifically indicated as a supplement in total intravenous nutrition for adults. Medical consensus confirms that supplementing trace elements is non-negotiable for patients dependent on intravenous feeding to avoid severe, systemic complications of mineral deficiency.

By supplying these elements, which function as crucial cofactors for numerous enzymes, Addamel supports the fundamental chemical processes essential for sustained cellular and organ function, enabling the maintenance of trace element balance during periods of severe nutritional stress, such as following major surgery or due to chronic intestinal failure.

What side effects are possible with Addamel?

Possible Side Effects and Safety Information

The official safety documentation for this multi-component trace element supplement emphasizes risks related to systemic administration and mineral balance, rather than typical pharmacological side effects. The frequency of key adverse reactions is often categorized as Not known because it cannot be accurately estimated from the available data, a common feature for total parenteral nutrition additives.

Key safety considerations are officially grouped by the regulatory bodies:

  • Immune System Disorders: The potential for hypersensitivity reactions is documented, which may include severe manifestations such as anaphylactic shock.
  • Hepatobiliary Disorders: There is a documented risk of Cholestasis and severe liver dysfunction associated with the accumulation of certain elements, particularly Manganese and Copper, which are excreted via the bile.
  • General Disorders: This class includes local reactions at the infusion site, such as localized pain or irritation.

Safety is closely tied to the patient's existing health status and duration of exposure. The risks of elemental accumulation and associated toxicity are explicitly linked to prolonged total parenteral nutrition (TPN). Therefore, the supplement is contraindicated in patients with severe hepatic impairment and in those with pre-existing, elevated plasma concentrations of any of the component trace elements. Patients with existing renal impairment or impaired bile excretion require specific safety considerations, as reduced clearance can heighten the risk of accumulation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation states that the primary risk associated with overdosage is the chronic accumulation of trace elements in the body, which is particularly increased in patients with impaired renal function or impaired biliary function.

Overdose may present with symptoms related to the toxicity of constituent elements, such as zinc poisoning, which is documented to include manifestations like hypotension, pulmonary oedema, diarrhoea, vomiting, jaundice, and oliguria. Chronic accumulation of iron can result in a severe outcome called haemosiderosis.

Overdose Action Required (Regulatory Mandate) Condition/Procedure
Diagnosis Confirmation Requires biochemical or haematological tests to confirm overdosage.
Immediate Action Mandates immediate withdrawal of the Addamel treatment upon diagnosis.
External Contact Regulatory instructions direct users to contact the National Poisons Centre for information on management.

In rare and severe instances of haemosiderosis arising from chronic iron overload, the official label notes that the condition can be treated by venesection. If symptoms such as hypotension or pulmonary oedema are observed, urgent medical attention is required.

Therapeutic Uses of Addamel

What Addamel Treats: Main Uses and Benefits

Addressing Core Deficiency in Total Parenteral Nutrition

Addamel is primarily used to manage the risk of, and address, established trace element deficiency in adult patients who require Total Parenteral Nutrition (TPN) because they cannot adequately absorb nutrients through the digestive tract. The official therapeutic indication is to meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults when either oral or enteral nutrition is inappropriate. The core benefit is providing essential elements like Zinc, Iron, and Selenium that contribute to sustaining critical physiological stability during necessary nutritional support.


Preventing Systemic Complications in High-Stress Scenarios

This supplement is applied in clinical settings marked by severe nutritional stress, such as following major surgery or in cases of chronic intestinal failure. By providing proactive micronutrient repletion, Addamel contributes to the body's resilience and assists with managing the risks associated with deficiency manifestations, supporting general well-being during symptomatic phases related to nutritional compromise.

Quick Fact: Support for Nutritional Stress The product is commonly used to address symptoms related to systemic imbalance when the patient cannot absorb essential minerals.

“The consistent and balanced supply of trace elements is considered important in intravenous feeding to support general physiological functioning.”

Regulatory References

  1. Therapeutic Goods Administration (TGA) Public Assessment Report

Eligibility and Restrictions for Use

Who can and cannot use Addamel?

The eligibility for Addamel is determined by official regulatory documents, which define absolute prohibitions (contraindications) and conditions requiring special caution to prevent the accumulation of the supplement’s trace elements.

Absolute Contraindications

Addamel must not be used in patients with a known hypersensitivity to any of its components or in those with specific medical conditions that cause trace element overload:

  • Wilson’s disease (due to copper accumulation risk).
  • Hemochromatosis (due to iron accumulation risk).
  • Total biliary obstruction, which severely impairs the excretion of elements like manganese and copper.

Age and Conditional Use Restrictions

While the product is primarily indicated for adult patients receiving intravenous nutrition, specific limitations apply to younger patients. The supplement is contraindicated in children weighing less than 15 kg, and some regulatory bodies state it is not recommended for use in children under 12 years of age.

Caution is required and close monitoring is necessary for older adults and patients with impaired renal function or impaired liver function/cholestasis, as these conditions can reduce the body's ability to excrete elements like zinc and manganese.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Addamel is focused on chemical compatibility requirements within intravenous feeding solutions and the risk of element accumulation due to patient-specific conditions, rather than typical metabolic drug-drug interactions. The regulatory documentation explicitly states that no interactions with other drugs have been observed at the concentrations present in the product.

Documented Interaction Patterns

The most significant interactions involve the mixing of the solution and the clearance of its trace elements:

  • Physical Compatibility Constraint: Addamel must only be added to or mixed with other medicinal products for which the chemical compatibility has been formally documented. This procedural requirement governs co-administration within the infusion setting.
  • In-Solution Exposure Effects: In the solution, elements such as Copper may accelerate the oxidative loss of co-administered ascorbic acid (Vitamin C), and co-administered amino acids may alter the clearance of Zinc and Copper by forming complexes that increase urinary elimination.
  • Cumulative Exposure: Regulatory cautions require that all sources of trace elements, such as oral iron supplements, be accounted for when determining total iron exposure to prevent the risk of metal accumulation.

Population-Dependent Accumulation Risk

Interactions are formally linked to a patient’s clearance capacity:

  • Impaired Renal Function: This condition increases the risk for element accumulation (e.g., Chromium, Zinc, Selenium) due to impaired urinary excretion.
  • Liver Dysfunction/Biliary Obstruction: This condition increases the risk for element accumulation (e.g., Copper, Manganese) due to impaired biliary excretion.

Contraindication for use is officially established in patients with total biliary obstruction due to the high risk of trace element accumulation.

Mechanism of Action

How Addamel Works

The mechanism of Addamel is fundamentally physiological replenishment, defined by supplying nine essential trace elements that function as obligate cofactors for the body's native biological machinery. This action restores the chemical basis for cellular activity rather than pharmacologically modifying pathways.

Enzyme Cofactor Integration and Catalysis

Elements such as Zinc, Manganese, and Molybdenum are supplied for cofactor donation to specific apoenzymes. This interaction completes the catalytic site, forming functional metalloenzymes that enable crucial biochemical reactions, thereby contributing to the function necessary for cellular respiration and fundamental metabolic pathways.

Systemic Energy and Hormonal Pathway Support

The elements influence systemic operations by providing indispensable structural components. Iron is incorporated into Hemoglobin for oxygen transport, while Iodine is the essential substrate for Thyroid Hormones ( T3/ T4) that influence the rate of cellular energy utilization. Additionally, Chromium acts as a potentiator, enhancing the efficiency of the native Insulin receptor signaling cascade, contributing to the efficiency of glucose uptake.

Dosage and Administration Information

How to Use Addamel

Addamel is a trace element supplement designed exclusively for patients receiving intravenous nutrition. Its usage is highly standardized and governed by strict protocols to ensure accurate delivery of essential micronutrients.


Administration Scope

The medicine is supplied as a concentrate for solution for infusion and must be administered strictly via the intravenous (IV) route. It is used as an additive in Total Parenteral Nutrition (TPN) and is never to be administered undiluted.

Category Official Administration Principle
Standard Adult Dose 10 mL (one ampoule) daily
Pediatric Dose (ge 15 kg) 0.1 mL/kg body weight per day
Dosing Frequency Administered once daily as part of the TPN regimen.
Preparation Requirement Must be diluted into a compatible parenteral nutrition solution.

Procedural Conditions and Time Window

Administration of Addamel requires adherence to specific procedural constraints detailed in the official product information. The preparation of the final mixed solution requires aseptic technique to prevent contamination. Once the concentrate is diluted into the infusion solution, administration must be completed within 24 hours. The product is for single use only; any unused portion of the ampoule must be discarded after the dose is prepared. Furthermore, the dosage may require adaptation for patients with pre-existing hepatic or renal impairment, reflecting the need for adjusted usage in these specific clinical scenarios.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Addamel

This section provides a descriptive summary of the research evidence and study structure related to the use of multi-trace element supplementation (like Addamel) for adult patients requiring Total Parenteral Nutrition (TPN). This information is derived from official sources and the established body of nutritional science.

Evidence for Use in Total Parenteral Nutrition (TPN) for Adults

The evidence base primarily relies on the long-established scientific understanding of the body's essential requirement for trace elements, which is a component of regulatory submissions. Because these elements (such as zinc, copper, and selenium) are necessary for basic life functions, regulatory bodies use the synthesis of existing data rather than single, large-scale, novel drug trials. Research has explored the relationship between trace element provision and the goal of maintaining adequate mineral status in TPN patients.

Studies reported measurements of trace element concentrations in the blood of observed populations receiving these supplements. These findings describe patterns observed in the studies related to trace element status in patients receiving fixed-dose mixtures. The research explores how to approach the maintenance of this nutrient balance when the digestive system cannot be used.


Types of Studies and Outcomes Examined

The studies research examined different approaches to providing trace elements, including shorter-term randomized controlled trials and observational cohort studies. Researchers primarily focused on biochemical endpoints as large, long-term, placebo-controlled trials for essential nutrients are not feasible.

The main outcomes monitored related to the maintenance of adequate trace element status, which is key for systemic and functional balance. Studies monitored outcomes linked to inflammatory or irritative states and focused on tracking specific biochemical markers. For example, research monitored patterns of blood levels of specific elements in TPN patients receiving the multi-trace element mixture.


What Remains Uncertain in the Research Landscape

The evidence landscape highlights the established necessity of trace element provision during parenteral nutrition but presents limitations regarding the fixed-dose approach. The evidence quality varies across studies, and there is a high reliance on biochemical maintenance rather than large-scale, hard clinical outcomes like survival or complication rates. The ethical impossibility of conducting placebo-controlled trials for essential nutrients means that comparative evidence is lacking for certain questions. Current research describes group patterns, and findings do not provide individual predictions.

Key Studies & References

  1. Clinical Guidelines on Parenteral Nutrition: Trace Elements (Meta-Analysis/Systematic Review)
  2. Trace Elements in Critical Illness and Parenteral Nutrition: Review of Established Requirements and Research Gaps

Frequently Asked Questions (FAQ)

Common questions about Addamel (FAQ)


Q: What are the most common side effects of Addamel reported in studies?

A: Regulatory documents describe that the frequency of many potential undesirable effects is often reported as 'not known' due to limitations in estimating occurrence from available data. Adverse reactions specifically caused by the trace elements in the mixture are not detailed in the product information. Documented possibilities include reactions at the infusion site and the risk of rare hypersensitivity reactions.


Q: Is it common for Addamel to cause weight gain or changes in appetite?

A: Official product information does not list weight gain, weight loss, or changes in appetite as documented undesirable effects. The medicine functions primarily as a nutritional supplement intended to maintain the body's essential mineral balance.


Q: Are there any long-term side effects associated with taking Addamel for years?

A: Official warnings indicate that prolonged use may increase the risk of element accumulation, particularly Manganese and Copper, in patients with impaired clearance capacity (like those with liver or kidney impairment). This accumulation has been associated with complications such as liver dysfunction or nerve-related issues. Due to these risks, monitoring of trace element plasma levels is required during long-term administration.


Q: Does Addamel interact with common over-the-counter pain relievers like ibuprofen?

A: Regulatory documentation states that no interactions with other medicines have been observed at the concentrations present in Addamel. This general safety statement applies to non-prescription pain relievers. The main interactions described relate instead to the chemical compatibility required within the intravenous solution itself.


Q: Can you drink alcohol while taking Addamel?

A: Official product information does not contain specific regulatory warnings against consuming alcohol. The documentation states that the medicine has no or negligible influence on the ability to drive or use machines. Specific guidance related to alcohol should be addressed within the context of the patient's overall care and nutritional regimen.


Q: Are there any specific foods or supplements that should be avoided with Addamel?

A: Regulatory cautions state that all other external sources of trace elements, such as oral iron supplements, must be accounted for to prevent the risk of element accumulation. Additionally, the presence of elements like Copper in the solution may accelerate the oxidative loss of co-administered Vitamin C. Since the product is administered intravenously, traditional food interactions are not a concern.


Q: Why do doctors prescribe Addamel instead of other similar medicines?

A: Addamel is described as a source of nine essential trace elements intended for patients receiving intravenous nutrition. The physiological mechanism involves replenishing cofactors to support basic cellular and metabolic pathways, differentiating it from medicines that act by pharmacologically modifying the body's systems.


Q: What does it mean that Addamel has a 'Black Box Warning' (if applicable)?

A: The official product labeling for Addamel does not contain a Black Box Warning. This type of warning is designated by regulatory bodies for serious safety concerns. In regions governed by the EMA, a similar inverted black triangle symbol may be used on certain medicines under additional monitoring to encourage the reporting of suspected side effects.


Q: Is Addamel a habit-forming or controlled substance?

A: Regulatory classification defines Addamel as a trace element supplement intended solely for nutritional replenishment. Because its purpose is physiological, supporting the body's natural processes, official sources do not classify it as a controlled substance or list it as habit-forming.


Q: What are the signs of a severe or allergic reaction to Addamel?

A: Official safety information notes the possibility of severe hypersensitivity reactions, including anaphylactic shock. Such reactions may involve changes like swelling, breathing difficulties, or changes in blood pressure. The administration of the medicine takes place in a clinical setting where healthcare providers monitor for any signs of an acute reaction.


Q: Does Addamel cause changes in sleep patterns or energy levels?

A: Official product information does not list changes in sleep patterns among the documented undesirable effects. The medicine's intended function is to replenish essential trace elements that support fundamental metabolic processes and cellular energy utilization.


Q: Can Addamel be taken by people with pre-existing heart conditions?

A: Regulatory cautions advise that TPN solutions containing sodium ions be used with care in patients who have pre-existing conditions like congestive heart failure (CHF) or issues with sodium retention. Aside from these fluid and electrolyte considerations, heart conditions are not listed as an absolute prohibition for the use of Addamel itself.


Q: Has Addamel been studied for use during pregnancy or while breastfeeding?

A: Clinical investigations in pregnant women have not been carried out. However, since trace element requirements are slightly increased during pregnancy and the elements are essential, adverse events are not generally expected from the use of the product. The active substances are known to be secreted into human milk.


Q: Is Addamel available as a generic drug, and is the generic the same as the brand name?

A: Addamel is a specific multi-trace element product. In some markets, official documents have addressed its use as a temporary substitute for other locally approved trace element injections, such as during drug shortages. Caution is advised when switching between products, as the specific mixture, dosing, or compatibility profile may differ from other approved products.


Q: Does taking Addamel affect your ability to drive or operate machinery?

A: Regulatory documentation states that Addamel has no or negligible influence on a person's ability to drive vehicles or operate machinery.


Q: Does Addamel interact with herbal supplements, such as St. John's Wort?

A: Official product information states that no interactions with other drugs have been observed at the concentrations found in Addamel. This general statement covers herbal products, which are not specifically listed as separate exceptions in the interaction profile. The main concerns relate to accounting for all external sources of trace elements.


Q: Are there any requirements for blood tests or lab work while taking Addamel?

A: Monitoring is required during treatment. Official guidance states that if administration continues for more than four weeks, checking of Manganese levels is required. In general, plasma levels of trace elements should be determined frequently during long-term administration to monitor for potential accumulation or deficiency.


Q: What is the difference between how Addamel is described versus how similar drugs work?

A: Official documents describe the medicine's function as providing nine essential trace elements for the physiological replenishment of cofactors. This approach supports the body's essential chemical processes directly. This mechanism is generally considered distinct from medicines that exert their effects by pharmacologically modifying the body’s receptors or specific pathways.

How should Addamel be stored and disposed of?

How to Store and Dispose of Addamel?

Addamel, a concentrate for solution for infusion, has strict regulatory storage requirements to ensure its stability.

Storage Conditions

Requirement Official Instruction
Temperature Store below 25 C or 30 C, depending on regional labeling.
Light Protection Keep the ampoules in the original outer carton to protect from light.
Freezing Do not freeze the medicinal product.
Child Safety Keep this medicine out of the sight and reach of children.

Stability and Handling

Addamel is for single use only. Once the concentrate is added to an infusion solution (diluted), the entire solution must be administered within 24 hours due to stability constraints. If not used immediately, the diluted solution must be refrigerated at 2-8 C for no longer than 24 hours.

Disposal Requirements

Any unused medicine or waste material, including leftover contents of opened ampoules, must be discarded. Disposal must be carried out in accordance with local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Addamel found in:

A-Z Index: